Literature DB >> 3003260

Cataracts induced by intermittent Decadron used as an antiemetic.

A Z Bluming, P Zeegen.   

Abstract

Recent reports have shown that Decadron (dexamethasone; Merck Sharp & Dohme, West Point, Pa) has a significant antiemetic effect on cisplatin-induced vomiting. Although the development of posterior subcapsular cataracts is a known complication of systemic steroid therapy, it usually occurs after several years of chronic administration. A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five-drug antiemetic regimen for cisplatin-associated nausea. This report is intended to alert others to the possible development of this serious complication following short-term Decadron therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003260     DOI: 10.1200/JCO.1986.4.2.221

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  2 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.

Authors:  M C Palmer; B M Colls
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.